Menopause Symptoms, Average Age and Diagnosis: What to Expect
Menopause is confirmed after 12 months without a period, usually around age 51. What the symptoms are, how it is diagnosed, how long it lasts and why early menopause needs attention.

Hot flushes in a meeting, nights broken by sweats, a period that is suddenly late and then heavy. Many women wonder whether this is "already menopause" and what it means for the years ahead. Menopause is not an illness, but it is a real biological change: the ovaries stop working, oestrogen falls, and that affects sleep, mood, the vagina and bladder, bones and the heart. Knowing the stages, the usual age and how doctors diagnose it helps you recognise what is happening.
In short: menopause is your final period, confirmed after 12 months in a row without bleeding. The average age is about 51, and most women reach it between 45 and 55. Over 45, doctors usually diagnose it from symptoms and your cycle, without blood tests; FSH testing is mainly for women under 45. Frequent hot flushes last a median of about 7 years, and menopause before 40 (premature ovarian insufficiency) or before 45 needs medical attention because of the long-term effects on bones and heart.
What is menopause?
The World Health Organization defines natural menopause as 12 consecutive months without a period, with no other obvious cause. It happens because the ovaries run out of follicles: they stop releasing eggs and produce much less oestrogen. Menopause is a single date, the last period, which you can only identify a year later.
Menopause can also be induced, by surgery that removes both ovaries or by treatments such as chemotherapy or pelvic radiotherapy. A hysterectomy that leaves the ovaries in place stops periods but is not, by itself, menopause.
Average age of menopause
The American College of Obstetricians and Gynecologists (ACOG) gives 51 as the average age of menopause, and the WHO notes that most women go through it between 45 and 55. The exact timing cannot be predicted for an individual woman, although family history, smoking and some health conditions are linked to an earlier menopause. NICE adds that women from some ethnic minority backgrounds and women with certain lifelong conditions may reach menopause younger.
The stages: perimenopause, menopause and postmenopause
| Stage | Definition | Typical age | What happens |
|---|---|---|---|
| Perimenopause (menopausal transition) | From the first changes in the cycle until 12 months after the last period | Usually mid-40s; hormone fluctuations can start in the late 30s | Irregular periods, hot flushes, poor sleep, mood swings; pregnancy is still possible |
| Menopause | The final menstrual period, confirmed after 12 months without bleeding | Average 51, usually 45–55 | Oestrogen is low and stays low; symptoms often peak around this time |
| Postmenopause | All the years after menopause | From about 52 onwards, for life | Hot flushes usually fade over years; vaginal dryness and bone loss can continue |
| Early menopause | Menopause between 40 and 44 | 40–44 | Same symptoms, but more years without oestrogen |
| Premature ovarian insufficiency (POI) | Loss of ovarian function before 40 | Under 40 | Missing or rare periods, menopausal symptoms, fertility problems; hormone replacement is recommended |
The early signs of the transition are covered in perimenopause symptoms, age and how long it lasts.
Menopause symptoms
Some women hardly notice anything; others have symptoms that affect work, relationships and sleep. NICE and the NHS list the most common:
- Vasomotor symptoms: hot flushes (sudden heat over the face, neck and chest, sometimes with palpitations, lasting a few minutes) and night sweats. Treatment options are in hot flashes and night sweats: what actually helps.
- Sleep problems, made worse by night sweats.
- Mood and thinking: irritability, low mood, anxiety, poorer memory and concentration ("brain fog").
- Genitourinary syndrome of menopause (GSM): vaginal dryness, burning and irritation, pain during sex, urinary urgency and recurrent urinary infections. Since 2014 the term GSM has replaced "vaginal atrophy", because the bladder and urethra are affected too.
- Joints, skin and hair: joint and muscle aches, dry itchy skin, thinning hair.
- Other: lower libido, worse headaches or migraines, palpitations, weight gain around the waist.
Important: any vaginal bleeding after 12 months without a period, even spotting, should be checked by a doctor. It is usually not serious, but it can be a sign of cancer.
How long does menopause last?
The NHS says symptoms usually last 7 to 9 years, sometimes longer, and can change along the way: hot flushes may fade while low mood or anxiety becomes more noticeable.
The American SWAN study (Avis et al., JAMA Internal Medicine, 2015) followed women for up to 17 years. Among those with frequent hot flushes, the median total duration was 7.4 years, and they continued for a median of 4.5 years after the last period. Women whose hot flushes started early in the transition had them longest (median more than 11.8 years); those whose hot flushes began only after menopause had them for the shortest time (median 3.4 years).
Signs that menopause is ending
No test shows "the end of menopause". Usually, hot flushes and night sweats become rarer and milder in the years after the last period, and sleep improves. Vaginal dryness and urinary symptoms, however, tend to persist or worsen without treatment, because the lack of oestrogen continues for life.
Menopause diagnosis: when is an FSH test needed?
Many women expect a blood test to "confirm menopause". The NICE NG23 guideline (last updated in 2026) says:
- Aged 45 or over, otherwise healthy, with symptoms: perimenopause and menopause are diagnosed without lab tests. Menopause means no period for at least 12 months while not using hormonal contraception.
- After a hysterectomy: diagnosis is based on the type and combination of symptoms.
- Between 40 and 45: the doctor may consider an FSH (follicle-stimulating hormone) test if there are symptoms and cycle changes.
- Under 40: FSH is used when premature ovarian insufficiency is suspected.
- AMH, inhibin, oestradiol and ovarian ultrasound measures are not recommended to identify menopause over 45.
- FSH is unreliable on combined hormonal contraception or high-dose progestogen.
During perimenopause hormones swing from week to week, so a single result can mislead. The doctor may still run other tests, such as thyroid tests, to rule out other causes.
Early menopause and premature ovarian insufficiency (POI)
Early menopause means menopause between 40 and 44; premature ovarian insufficiency (sometimes called premature menopause) means loss of ovarian function before 40. The 2024 international guideline from ESHRE, ASRM, CRE-WHiRL and the International Menopause Society estimates POI affects about 3.5% of women, more than once thought. According to the NHS, the risk is higher with a family history, early first periods, smoking or being underweight, and after chemotherapy, radiotherapy or removal of the ovaries.
Diagnosis: NICE requires menopausal symptoms plus raised FSH on two samples taken 4–6 weeks apart, never a single test. The 2024 ESHRE guideline accepts one raised FSH (above 25 IU/L) with symptoms, repeating the test or adding AMH when the diagnosis is uncertain.
Why treatment matters: many more years without oestrogen raise the risk of osteoporosis and cardiovascular disease. NICE recommends offering women with POI hormone replacement therapy or a combined hormonal contraceptive, unless contraindicated (for example, a hormone-sensitive cancer), and continuing it at least until the age of natural menopause. The baseline risk of breast cancer and heart disease is very low before 40, so the balance differs from that of a 55-year-old. For early menopause, NICE says the benefits and risks of HRT lie between those for POI and those for women over 45. Psychological support should be offered if the diagnosis is distressing.
Surgical menopause
Surgical menopause is the removal of both ovaries (bilateral oophorectomy) before natural menopause, often during a hysterectomy, for endometriosis, cancer or risk reduction in BRCA carriers. The British Menopause Society notes that because ovarian function stops suddenly, symptoms can be particularly severe and loss of libido more pronounced. Younger women also face higher cardiovascular and osteoporosis risk. HRT plays a significant role, especially under 45, if there are no contraindications; after risk-reducing surgery in BRCA carriers it can generally be used until the expected age of natural menopause. NICE recommends a discussion about menopause and fertility before and after any treatment expected to cause menopause.
Menopause and osteoporosis
Everyone loses a little bone each year from about 35, but according to ACOG women lose bone much faster in the first 4–8 years after menopause. Too much loss leads to osteoporosis and fragility fractures of the hip, wrist and spine. Weight-bearing exercise, strength and balance training, enough calcium and vitamin D, and not smoking all help. HRT reduces fracture risk while it is taken; the benefit fades after stopping. Your doctor decides whether you need a bone density (DXA) scan.
Menopause and heart disease
Cardiovascular disease is the leading cause of death in women. A 2020 American Heart Association statement describes the menopausal transition as a time of accelerating cardiovascular risk: fat distribution changes, LDL cholesterol rises and vascular health worsens. NICE says HRT should not be used to prevent heart disease; prevention means controlling blood pressure, cholesterol and blood sugar, staying active and not smoking. The cardiovascular risk calculator (SCORE2) gives an estimate to discuss with your doctor.
Menopause treatment: an overview
| Option | Helps with | Notes |
|---|---|---|
| Lifestyle | Bones, heart, sleep, general health | Exercise, weight control, no smoking, less alcohol |
| Systemic HRT (patch, gel, spray, tablets) | Hot flushes, night sweats, sleep, mood, bone protection | Most effective for hot flushes; a progestogen is needed if you have a womb |
| Vaginal oestrogen | Dryness, painful sex, urinary symptoms | Acts locally with minimal absorption; can be added to systemic HRT |
| Vaginal moisturisers and lubricants | Mild dryness | Non-hormonal |
| Menopause-specific CBT | Hot flushes, sleep, mood | Recommended by NICE with or instead of HRT |
| Non-hormonal medicines | Hot flushes when HRT is unsuitable | For example fezolinetant; some antidepressants or gabapentin in selected cases |
The Menopause Society's 2022 position statement concludes that for women under 60 or within 10 years of menopause without contraindications, the benefit-risk ratio of hormone therapy is favourable for bothersome hot flushes and preventing bone loss; started later, absolute risks (heart disease, stroke, blood clots, dementia) are higher. See HRT benefits and risks: is it safe? and types of HRT: patch, gel or tablets.
Tracking symptoms and treatment
Symptoms change from month to month and treatment is often adjusted, so a simple log helps you and your doctor see what works. Besides a notebook, you can use Amelie (partner app, iPhone): it logs hot flushes, night sweats, sleep, mood, energy, brain fog, joint pain and your own symptoms, and shows them week by week since each HRT change (patch, gel, dose) so you can compare treatment periods. It also tracks check-ups such as mammograms and bone density scans, and creates a one-page PDF summary for your appointment. Data stays on the phone, with no account; there is a 1-week free trial, then a subscription. Amelie does not diagnose, predict periods, interpret lab results or suggest doses, and Nexmed does not medically endorse it. You can read more about this menopause tracker app on amelie.health.
Conclusion
Menopause is confirmed after 12 months without a period, usually around 51. Over 45, diagnosis is clinical; under 45, and especially under 40, FSH testing and a discussion about hormone replacement matter. Hot flushes often last more than 7 years, while vaginal dryness and bone loss can continue afterwards, which makes menopause a good moment to check bones and heart. Effective hormonal and non-hormonal treatments exist, chosen together with your gynaecologist or GP.
Frequently asked questions
What is the average age of menopause? The average age is about 51, and most women reach menopause between 45 and 55. Menopause before 45 is called early menopause, and before 40 premature ovarian insufficiency.
Do I need an FSH test to confirm menopause? Generally not if you are over 45, when the diagnosis is based on symptoms and 12 months without a period. NICE suggests considering FSH only between 40 and 45 or under 40, and it is unreliable on combined hormonal contraception.
How long do menopause symptoms last? The NHS says usually 7 to 9 years, sometimes longer. In the SWAN study, frequent hot flushes lasted a median of 7.4 years, about 4.5 of them after the last period.
What are the signs that menopause is ending? Hot flushes and night sweats gradually become rarer and milder, and sleep improves. Vaginal dryness and urinary symptoms often persist or worsen without treatment.
What is premature ovarian insufficiency and why should it be treated? It is loss of ovarian function before 40, affecting about 3.5% of women. Hormone replacement is recommended at least until the natural age of menopause to protect bones and heart, unless there is a contraindication.
Can I get pregnant during perimenopause? Yes. The NHS advises contraception for 2 years after your last period if you are under 50, and for 1 year if you are 50 or over.
Is bleeding after menopause normal? No. Any bleeding after 12 months without a period, even spotting, should be checked by a doctor.
Read next
- Perimenopause: early signs, age and how long it lasts
- HRT benefits and risks: is hormone therapy safe?
- Types of HRT: patch, gel or tablets compared
- Hot flashes and night sweats: what helps, from lifestyle to medicines
Useful tools
- Cardiovascular risk calculator (SCORE2): estimate your 10-year risk of heart attack and stroke.
- BMI calculator: check whether your weight is in a healthy range.
- BMR calculator: estimate your daily calorie needs as metabolism changes in midlife.
Sources
- NICE. Menopause: identification and management (NG23). 2015, last updated 2026. https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
- World Health Organization. Menopause – fact sheet. https://www.who.int/news-room/fact-sheets/detail/menopause
- ACOG. The Menopause Years (FAQ). https://www.acog.org/womens-health/faqs/the-menopause-years
- NHS. Symptoms of menopause and perimenopause. 2026. https://www.nhs.uk/conditions/menopause/symptoms/
- NHS. Early or premature menopause. https://www.nhs.uk/conditions/early-menopause/
- Avis NE et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015. https://pubmed.ncbi.nlm.nih.gov/25686030/
- Panay N et al.; ESHRE, ASRM, CRE-WHiRL and IMS Guideline Group on POI. Evidence-based guideline: premature ovarian insufficiency. Hum Reprod Open. 2024. https://pubmed.ncbi.nlm.nih.gov/39660328/
- British Menopause Society. Surgical menopause: a toolkit for healthcare professionals. 2024. https://thebms.org.uk/wp-content/uploads/2024/10/13-BMS-TfC-Surgical-Menopause-SEPT2024-D.pdf
- Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy. Maturitas. 2014. https://pubmed.ncbi.nlm.nih.gov/25179577/
- El Khoudary SR et al. Menopause Transition and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association. Circulation. 2020. https://pubmed.ncbi.nlm.nih.gov/33251828/
- The North American Menopause Society. The 2022 hormone therapy position statement. Menopause. 2022. https://pubmed.ncbi.nlm.nih.gov/35797481/
- The North American Menopause Society. The 2023 nonhormone therapy position statement. Menopause. 2023. https://pubmed.ncbi.nlm.nih.gov/37252752/
Informational material, updated November 2026. It does not replace advice from your doctor.
This article is for general information only and does not replace advice from your doctor or pharmacist. Do not start, stop or change a treatment without medical supervision.


